Vertex Pharmaceuticals, Inc. (VRTX)
438.71
-8.55
(-1.91%)
USD |
NASDAQ |
Apr 02, 16:00
438.30
-0.41
(-0.09%)
After-Hours: 20:00
Vertex Pharmaceuticals Total Assets (Quarterly) : 26.14B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 59.02B |
| Amgen, Inc. | 90.59B |
| Moderna, Inc. | 12.34B |
| Eli Lilly & Co. | 112.48B |
| Regeneron Pharmaceuticals, Inc. | 40.56B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.477B |
| Shareholders Equity (Quarterly) | 18.67B |
| Debt to Equity Ratio | 0.1091 |
| Current Ratio | 2.901 |
| Net Debt Paydown Yield | -0.06% |